Pyrido[2,3-b]pyrazine-8-substituted compounds and their use

Details for Australian Patent Application No. 2008337286 (hide)

Owner Cancer Research Technology Limited Institute of Cancer Research: Royal Cancer Hospital (The)

Inventors Menard, Delphine; Zambon, Alfonso; Springer, Caroline Joy; Marais, Richard; Suijkerbuijk, Bartholomeus Marinus Josephus Marie; NiculescuDuvaz, Dan; Niculescu-Duvaz, Ion; Nourry, Arnaud

Agent FB Rice

Pub. Number AU-A-2008337286

PCT Pub. Number WO2009/077766

Priority 61/015,019 19.12.07 US

Filing date 19 December 2008

Wipo publication date 25 June 2009

International Classifications

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

15 July 2010 PCT application entered the National Phase

  PCT publication WO2009/077766 Priority application(s): WO2009/077766

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008337292-Improvemements in or relating to display projectors

2008337284-Compounds and methods for the treatment of vascular disease